These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 21086083

  • 1. Response surface methodology to optimize novel fast disintegrating tablets using β cyclodextrin as diluent.
    Late SG, Banga AK.
    AAPS PharmSciTech; 2010 Dec; 11(4):1627-35. PubMed ID: 21086083
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF, Ibrahim MA, Sakr A.
    Pharm Dev Technol; 2013 Dec; 18(2):454-63. PubMed ID: 22881389
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression.
    Obaidat AA, Obaidat RM.
    Acta Pharm; 2011 Mar; 61(1):83-91. PubMed ID: 21406346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets.
    Late SG, Yu YY, Banga AK.
    Int J Pharm; 2009 Jan 05; 365(1-2):4-11. PubMed ID: 18778759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W, Akkaramongkolporn P, Ngawhirunpat T, Rojanarata T, Opanasopit P.
    Drug Dev Ind Pharm; 2015 Jun 05; 41(6):1006-16. PubMed ID: 24865111
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.